Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives.

AML clinical trial resistance targeted therapy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
16 Nov 2021
Historique:
received: 25 10 2021
revised: 07 11 2021
accepted: 12 11 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 28 11 2021
Statut: epublish

Résumé

Treatment of acute myeloid leukemia (AML) has improved in recent years and several new therapeutic options have been approved. Most of them include mutation-specific approaches (e.g., gilteritinib for AML patients with activating

Identifiants

pubmed: 34830877
pii: cancers13225722
doi: 10.3390/cancers13225722
pmc: PMC8616498
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

N Engl J Med. 2019 Jan 3;380(1):45-56
pubmed: 30501490
Cell Mol Life Sci. 2009 Apr;66(8):1326-36
pubmed: 19099185
Clin Cancer Res. 2016 Feb 15;22(4):868-76
pubmed: 26459177
Blood. 2018 Jan 25;131(4):468-471
pubmed: 29229596
N Engl J Med. 2018 Feb 1;378(5):439-448
pubmed: 29385370
Expert Opin Biol Ther. 2019 Jul;19(7):721-733
pubmed: 31286786
Blood. 2020 Feb 13;135(7):463-471
pubmed: 31841594
Blood. 2011 Aug 11;118(6):1504-15
pubmed: 21670473
Leuk Res. 2015 Feb;39(2):216-20
pubmed: 25533931
Cancer Discov. 2019 Jul;9(7):910-925
pubmed: 31048320
J Clin Oncol. 2021 Sep 1;39(25):2768-2778
pubmed: 34043428
Am J Hematol. 2020 Jul 6;:
pubmed: 32628327
Sci Transl Med. 2019 Oct 30;11(516):
pubmed: 31666400
Blood. 2013 Jun 6;121(23):4655-62
pubmed: 23613521
Nature. 2016 Oct 27;538(7626):477-482
pubmed: 27760111
Blood. 2012 Jun 21;119(25):6089-98
pubmed: 22446485
Blood. 2007 Apr 1;109(7):2985-8
pubmed: 17119119
Haematologica. 2019 Jan;104(1):113-119
pubmed: 30076173
Nat Cancer. 2020 Aug;1(8):826-839
pubmed: 33123685
Blood. 2013 Jun 13;121(24):4854-60
pubmed: 23591789
Cancer Cell. 2017 Dec 11;32(6):748-760.e6
pubmed: 29232553
N Engl J Med. 2017 Mar 2;376(9):836-847
pubmed: 28249141
Cancer Discov. 2019 Jul;9(7):890-909
pubmed: 31048321
Nat Rev Mol Cell Biol. 2014 Jan;15(1):49-63
pubmed: 24355989
Blood. 2020 Dec 24;136(26):3041-3050
pubmed: 33367545
Oncotarget. 2017 Oct 27;8(63):106948-106961
pubmed: 29291002
Nat Med. 2018 Dec;24(12):1859-1866
pubmed: 30420752
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Am J Hematol. 2019 Aug;94(8):913-920
pubmed: 31145495
Haematologica. 2020 Mar;105(3):697-707
pubmed: 31123034
Future Oncol. 2020 May;16(13):807-815
pubmed: 32167393
Nat Genet. 2003 Jun;34(2):148-50
pubmed: 12717436
JAMA Oncol. 2018 Aug 1;4(8):1106-1110
pubmed: 29346478
Blood. 1998 Feb 1;91(3):991-1000
pubmed: 9446661
Blood Adv. 2020 May 12;4(9):1894-1905
pubmed: 32380538
Leukemia. 2011 Jul;25(7):1147-52
pubmed: 21494260
Cancer Discov. 2018 Dec;8(12):1566-1581
pubmed: 30185627
Lancet Oncol. 2018 Feb;19(2):216-228
pubmed: 29339097
Blood Cancer J. 2017 Mar 10;7(3):e542
pubmed: 28282031
Blood. 2021 Sep 30;138(13):1120-1136
pubmed: 34320168
Blood. 2009 Apr 9;113(15):3568-76
pubmed: 19204327
Front Oncol. 2021 Mar 11;11:649209
pubmed: 33777810
J Clin Oncol. 2017 Aug 10;35(23):2674-2682
pubmed: 28644774
Cancers (Basel). 2018 May 24;10(6):
pubmed: 29795051
Cancer Cell. 2010 Mar 16;17(3):225-34
pubmed: 20171147
Blood. 2020 Jun 11;135(24):2137-2145
pubmed: 32219442
Leukemia. 2013 Jun;27(6):1229-35
pubmed: 23314834
Ann Hematol. 2021 Apr;100(4):959-968
pubmed: 33191481
J Clin Oncol. 2021 May 10;39(14):1584-1594
pubmed: 33449813
Cancer Drug Resist. 2021;4:125-142
pubmed: 33796823
Oncotarget. 2015 Apr 20;6(11):9612-26
pubmed: 25823822
Leukemia. 2019 Jan;33(1):262-266
pubmed: 30008477
Oncotarget. 2017 Nov 3;8(63):107206-107222
pubmed: 29291023
Cancer Manag Res. 2019 Apr 23;11:3197-3213
pubmed: 31118772
Clin Cancer Res. 2019 Nov 15;25(22):6815-6826
pubmed: 31320594
N Engl J Med. 2019 Oct 31;381(18):1728-1740
pubmed: 31665578
J Clin Oncol. 2013 Dec 10;31(35):4424-30
pubmed: 24127442
Blood. 2001 Apr 15;97(8):2434-9
pubmed: 11290608
Blood. 2021 Feb 11;137(6):751-762
pubmed: 32929488
Biol Blood Marrow Transplant. 2018 Oct;24(10):2017-2024
pubmed: 29933073
Trends Biochem Sci. 2003 Jun;28(6):284-93
pubmed: 12826400
J Clin Oncol. 2019 May 20;37(15):1277-1284
pubmed: 30892988
Blood Cancer J. 2021 Feb 1;11(2):25
pubmed: 33563904
Mol Cancer Ther. 2011 Dec;10(12):2340-9
pubmed: 21914853
Blood. 2007 Mar 1;109(5):2264-5; author reply 2265
pubmed: 17312001
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
Leukemia. 1996 Dec;10(12):1911-8
pubmed: 8946930
Zhonghua Yi Xue Za Zhi. 2005 Jul 20;85(27):1903-6
pubmed: 16255985
Leukemia. 2017 Jan;31(1):1-10
pubmed: 27389053
Cancer Discov. 2016 Oct;6(10):1106-1117
pubmed: 27520294
Leuk Lymphoma. 2020 Feb;61(2):387-396
pubmed: 31545113
Cancer. 2021 Aug 15;127(16):2943-2953
pubmed: 33934351
Biol Blood Marrow Transplant. 2020 Dec;26(12):e322-e327
pubmed: 32866594
Nature. 2009 Dec 10;462(7274):739-44
pubmed: 19935646
Leukemia. 2021 Jul;35(7):1843-1863
pubmed: 33953290
Cancer Discov. 2017 Dec;7(12):1376-1393
pubmed: 29146569
Am J Hematol. 2015 Aug;90(8):732-6
pubmed: 26016821
Science. 2013 May 3;340(6132):626-30
pubmed: 23558169
Blood. 2007 May 1;109(9):4020-2
pubmed: 17202314
Leukemia. 2020 Nov;34(11):2858-2874
pubmed: 32651541
Blood. 2002 Oct 1;100(7):2393-8
pubmed: 12239147
Oncoimmunology. 2016 Jun 29;5(7):e1195535
pubmed: 27622049
Blood Adv. 2021 Sep 14;5(17):3279-3289
pubmed: 34459887
Leukemia. 2013 Feb;27(2):398-408
pubmed: 23103841
Blood. 2015 Jul 16;126(3):291-9
pubmed: 25987659
Int J Cancer. 2008 Jul 1;123(1):8-13
pubmed: 18425818
Lancet Oncol. 2020 Sep;21(9):1201-1212
pubmed: 32791048
Cancer Cell. 2010 Dec 14;18(6):553-67
pubmed: 21130701
Leukemia. 2008 Aug;22(8):1539-41
pubmed: 18528419
Leukemia. 2015 Jun;29(6):1290-300
pubmed: 25650089
Curr Med Chem. 2008;15(13):1274-87
pubmed: 18537607
Cancer Cell. 2006 May;9(5):351-65
pubmed: 16697956
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
J Exp Med. 2017 Feb;214(2):359-380
pubmed: 28031480
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4622-7
pubmed: 23471998
Haematologica. 2021 Apr 01;106(4):1034-1046
pubmed: 32414851
Haematologica. 2018 Sep;103(9):e404-e407
pubmed: 29545346
Exp Hematol. 2008 Oct;36(10):1285-96
pubmed: 18640765
J Clin Oncol. 2020 Sep 10;38(26):2993-3002
pubmed: 32673171
Front Immunol. 2021 Apr 01;12:618710
pubmed: 33868234
Blood Adv. 2019 Jul 9;3(13):1939-1949
pubmed: 31253596
Blood. 2021 Jun 3;137(22):3093-3104
pubmed: 33598693
Nat Med. 2020 Sep;26(9):1459-1467
pubmed: 32601337
Blood Cancer J. 2012 Mar;2(3):e60
pubmed: 22829255
Blood. 2019 Feb 14;133(7):676-687
pubmed: 30510081
Clin Cancer Res. 2021 Jan 1;27(1):60-69
pubmed: 32998965
Clin Cancer Res. 2020 Dec 1;26(23):6132-6140
pubmed: 32998961
Nat Commun. 2020 Feb 17;11(1):928
pubmed: 32066721
Signal Transduct Target Ther. 2017 Apr 07;2:17012
pubmed: 29263915
Cell Stem Cell. 2015 Sep 3;17(3):341-52
pubmed: 26279267
Blood. 2009 Apr 23;113(17):4074-7
pubmed: 18483393
Haematologica. 2016 Nov;101(11):e457-e460
pubmed: 27418649
Leukemia. 2022 Jan;36(1):90-99
pubmed: 34316017
Leuk Lymphoma. 2021 Jun;62(6):1432-1440
pubmed: 33399480
Leukemia. 2019 Feb;33(2):379-389
pubmed: 30555165
Cancer Cell. 2011 Jan 18;19(1):138-52
pubmed: 21251617
Am J Hematol. 2020 Dec;95(12):1511-1521
pubmed: 32833294
Leukemia. 2021 Sep;35(9):2482-2495
pubmed: 34131281
N Engl J Med. 2009 Sep 10;361(11):1058-66
pubmed: 19657110
Nature. 2015 Aug 6;524(7563):114-8
pubmed: 26200337
J Clin Med. 2021 Apr 14;10(8):
pubmed: 33919958
Cancer Discov. 2017 May;7(5):478-493
pubmed: 28193778
Lancet Oncol. 2019 Jul;20(7):984-997
pubmed: 31175001
J Natl Compr Canc Netw. 2017 Jul;15(7):926-957
pubmed: 28687581
Nat Commun. 2018 Dec 17;9(1):5341
pubmed: 30559424
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
PLoS One. 2015 Aug 21;10(8):e0135520
pubmed: 26296092
Blood. 2009 Sep 17;114(12):2386-92
pubmed: 19602710
Leukemia. 2014 Jan;28(1):78-87
pubmed: 24045501
J Clin Oncol. 2012 Jul 20;30(21):2670-7
pubmed: 22689805
PLoS One. 2010 Feb 02;5(2):e9001
pubmed: 20126405
Lancet. 2012 Apr 21;379(9825):1508-16
pubmed: 22482940
Cancers (Basel). 2021 May 01;13(9):
pubmed: 34062779
Biology (Basel). 2021 Mar 24;10(4):
pubmed: 33804919
Mol Pharmacol. 2013 Sep;84(3):438-50
pubmed: 23814180
Cancer Cell. 2017 Oct 9;32(4):506-519.e5
pubmed: 29017060
Am J Hematol. 2018 Mar;93(3):401-407
pubmed: 29218851
Blood. 2021 Jul 29;138(4):318-330
pubmed: 34323938
Cell. 2009 Jul 23;138(2):286-99
pubmed: 19632179
Nat Commun. 2015 Oct 07;6:8489
pubmed: 26444494
N Engl J Med. 2020 Dec 24;383(26):2526-2537
pubmed: 33369355
Blood. 2003 Oct 1;102(7):2395-402
pubmed: 12805060
Curr Opin Genet Dev. 2007 Feb;17(1):23-30
pubmed: 17227708
Curr Cancer Drug Targets. 2020;20(7):490-500
pubmed: 32329690
Mol Cancer Ther. 2020 Sep;19(9):1875-1888
pubmed: 32518207
Am J Hematol. 2018 May 17;:
pubmed: 29770480
N Engl J Med. 2018 Jun 21;378(25):2386-2398
pubmed: 29860938
Nat Med. 2018 Mar;24(3):282-291
pubmed: 29431743
Nature. 2016 Dec 15;540(7633):433-437
pubmed: 27926740
Cell Death Differ. 2018 Jan;25(1):27-36
pubmed: 29099483
N Engl J Med. 2009 Feb 19;360(8):765-73
pubmed: 19228619
Biol Blood Marrow Transplant. 2016 Jul;22(7):1218-1226
pubmed: 27058617
Blood. 2020 Nov 19;136(21):2442-2456
pubmed: 32589720
Onco Targets Ther. 2019 Sep 11;12:7477-7488
pubmed: 31686853
Nature. 2018 Jul;559(7712):125-129
pubmed: 29950729
Blood Adv. 2019 Dec 23;3(24):4215-4227
pubmed: 31856268
Trends Biochem Sci. 2013 Aug;38(8):394-402
pubmed: 23850066
Cancers (Basel). 2020 Dec 12;12(12):
pubmed: 33322769
Blood. 2009 Jan 15;113(3):659-67
pubmed: 18931345
Am J Hematol. 2020 Sep;95(9):1006-1014
pubmed: 32390196
J Biol Chem. 2013 Feb 8;288(6):3804-15
pubmed: 23264629
Cell. 2009 Jul 23;138(2):271-85
pubmed: 19632178
Blood Cancer J. 2022 May 30;12(5):84
pubmed: 35637252
Leukemia. 2004 Jul;18(7):1223-30
pubmed: 15152266
J Clin Oncol. 2020 Feb 20;38(6):623-632
pubmed: 31851556
Semin Oncol. 2005 Oct;32(5):511-20
pubmed: 16210092
Blood. 2020 Mar 12;135(11):791-803
pubmed: 31932844
J Hematol Oncol. 2015 Oct 20;8:114
pubmed: 26483188
N Engl J Med. 2020 Aug 13;383(7):617-629
pubmed: 32786187
Clin Cancer Res. 2017 Nov 1;23(21):6430-6440
pubmed: 28765326
Front Oncol. 2021 May 03;11:659253
pubmed: 34012921
Blood. 2021 Sep 23;138(12):1067-1080
pubmed: 34115113
Blood. 2001 Oct 15;98(8):2301-7
pubmed: 11588023
N Engl J Med. 2017 Aug 3;377(5):454-464
pubmed: 28644114
Blood. 2020 Mar 5;135(10):713-723
pubmed: 31951650
Blood. 2002 Oct 1;100(7):2387-92
pubmed: 12239146
Blood. 2009 Apr 23;113(17):4063-73
pubmed: 19144992
Blood Adv. 2020 Oct 13;4(19):4945-4954
pubmed: 33049054

Auteurs

Maximilian Fleischmann (M)

Klinik für Innere Medizin II, Abteilung Hämatologie und Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07740 Jena, Germany.

Ulf Schnetzke (U)

Klinik für Innere Medizin II, Abteilung Hämatologie und Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07740 Jena, Germany.

Andreas Hochhaus (A)

Klinik für Innere Medizin II, Abteilung Hämatologie und Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07740 Jena, Germany.

Sebastian Scholl (S)

Klinik für Innere Medizin II, Abteilung Hämatologie und Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07740 Jena, Germany.

Classifications MeSH